Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Oct;21(5):585-93.
doi: 10.1097/MOP.0b013e32832e48df.

Clinical research directions in pediatric cardiology

Affiliations
Review

Clinical research directions in pediatric cardiology

Steven E Lipshultz et al. Curr Opin Pediatr. 2009 Oct.

Abstract

Purpose of review: Clinical research in pediatric cardiology is under-appreciated and under-funded, yet it has enormous implications for cardiovascular health and healthcare over the entire life-course. Renewed interest in federally funded clinical research makes it timely to propose a comprehensive research agenda that, with its associated rationale, will attract public funds for research into child cardiovascular health and disease.

Recent findings: We propose here a comprehensive pediatric cardiology research agenda consisting of 22 topics and associated research questions. We describe the following five topics in more detail: the need for life-course studies of pediatric cardiac disease and epigenetic factors for later onset of cardiovascular effects; the need to study cardiometabolic disease risk in children; recent pediatric cardiology clinical trials and observational studies; the need to explore the role of physical activity in preventing and treating pediatric cardiology patients; and the need to develop and implement evidence-based interventions to manage pediatric cardiovascular problems.

Summary: If the field of pediatric cardiology can adopt a comprehensive research agenda that identifies the most-needed studies, then research could be better coordinated, long-term and collaborative studies would be more readily organized and funded, and the overall financial and scientific efficiency of research in pediatric cardiology would be improved. Targeted research efforts are more likely to realize potential breakthroughs in areas such as genetic and epigenetic screening, biomarkers, cardioprotective strategies, life-course studies, long-term monitoring technologies, environmental influences on disease, evidence-based practice guidelines, and more rapid and safer development of drugs.

PubMed Disclaimer

Conflict of interest statement

Disclosures: No conflicts of interest or sponsorships are noted.

Similar articles

Cited by

References

    1. Lipshultz SE. Ventricular dysfunction clinical research in infants, children and adolescents. Prog Ped Cardiol. 2000;12(1):1–28. - PubMed
    1. Lipshultz SE. Realizing optimal care for children with cardiovascular disease: Funding challenges and research approaches. Prog Pediatr Cardiol. 2005;20:71–90.
    1. Wilkinson JD, Lipshultz SE. Epidemiological and outcomes research in children with pediatric cardiomyopathy: discussions from the international workshop on primary and idiopathic cardiomyopathies in children. Prog Pediatr Cardiol. 2008;25(1):23–5. - PMC - PubMed
    2. Consensus recommendations on pediatric cardiomyopathy clinical research future directions from an NIH-sponsored international workshop.

    1. Lipshultz SE, Alvarez GA, Scully RE. Anthracycline-associated cardiotoxicity in survivors of childhood cancer. Heart. 2008;94(4):525–33. - PubMed
    2. Overview of anthracycline cardiotoxicity in childhood cancer survivors.

    1. Gianni L, Herman EH, Lipshultz SE, et al. Anthracycline cardiomyopathy: from bench to bedside. J Clin Oncol. 2008;26(22):3777–84. - PMC - PubMed
    2. Comprehensive translational research on anthracycline cardiotoxicity.

Publication types